increase in UA level, 15 but there was substantial heterogeneity across studies and control for confounding was limited. Importantly, none of those studies was able to adjust simultaneously for kidney function and for insulin resistance, two major confounders of the association between UA and hypertension. Furthermore, no studies to date have investigated the relationship between change in UA concentrations over time and development of incident hypertension.
We hypothesized that both higher initial UA concentrations and further increases in UA concentration over time would be associated with increased risk of incident hypertension. We have thus investigated the relationship between: (i) baseline serum UA concentrations and (ii) change in UA concentrations over time, with the development of incident hypertension over 8 years of follow-up, adjusting for key potential confounders, including measures of renal function and insulin resistance.
METHODS
The study population included South Korean men and women ≥18 years old who underwent a comprehensive health examination at the Kangbuk Samsung Hospital Health Screening Centers in Seoul and Suwon, South Korea, between 2002 and 2010. The purpose of the comprehensive health screening program is to promote health through early detection of chronic diseases and their risk factors. In Korea, the Industrial Safety and Health Law requires employees to participate in annual or biennial health examinations. About 80% of the participants were employees of various companies and local governmental organizations and their spouses with the remaining participants registering individually for the program.
The present analysis initially included all study participants with at least one follow-up visit for endpoint ascertainment between 2002 and 2010 (N = 136,158; 84,045 men and 52,113 women). Participants were excluded at baseline if they had hypertension (defined as self-reported history of hypertension, current use of antihypertensive medications, a systolic blood pressure ≥140 mm Hg or a diastolic blood pressure ≥90 mm Hg; N = 20,585), or if they reported a history of coronary artery disease, cardiovascular disease, cancer, diabetes, metabolic syndrome (N = 24,978). We further excluded participants with missing data at baseline for serum UA (N = 2) or any relevant adjustment covariates (N = 6,181). The final number of study participants was 96,606 (55,035 men and 41,571 women). To test the association between UA concentration change and incident hypertension, we restricted the analysis to participants with at least 3 visits (N = 61,777). The first two visits were used to determine UA concentration change (calculated as UA concentration in the second visit minus baseline UA concentration), and incident hypertension was determined from the second visit through the rest of follow-up. After excluding 5,692 individuals from the original cohort who had incident hypertension diagnosed at the second visit, this analysis included 56,085 participants (33,073 men and 23,012 women). The study was approved by the Institutional Review Board of Kangbuk Samsung Hospital. Individual informed consent was not required because all personal identifiable information was removed prior to accessing data collected for screening purposes.
Data on medical history, medication use, and healthrelated behaviors were collected through a self-administered questionnaire. Questionnaire data included years of education, smoking status (never, current, or former), weekly frequency of physical activity, and average amount of alcohol intake each day.
Physical measurements and serum biochemical parameters were measured by trained staff. Body weight was measured in light clothing and no shoes to the nearest 0.1 kg using a digital scale. Height was measured to the nearest 0.1 cm. BMI was calculated as weight in kilograms divided by height in meters squared. Waist circumference was measured as the midpoint between iliac crest and rib cage at end-expiration. Blood pressure was measured in the seated position after a period of resting sitting upright with standard mercury sphygmomanometers. If the systolic blood pressure was ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg, the measurement was repeated 2 more times after a rest at the same visit and then the values were averaged. At baseline and at each follow-up visit, hypertension was defined as a selfreported history of hypertension, current use of antihypertensive medications, a systolic blood pressure ≥140 mm Hg or a diastolic blood pressure ≥90 mm Hg.
Blood specimens were sampled from the antecubital vein after an overnight 12-hour fast. Biochemical analyses were performed centrally. The clinical laboratory has been accredited and participates annually in inspections and surveys by the Korean Association of Quality Assurance for Clinical Laboratories. Serum levels of glucose, total cholesterol, triglyceride, low-density lipoprotein cholesterol, and highdensity lipoprotein cholesterol were measured using Bayer Reagent Packs (Bayer Diagnostics, Leverkusen, Germany) on an automated chemistry analyzer (Advia 1650 autoanalyzer; Bayer Diagnostics). Serum UA was measured using the Fossati enzymatic reaction using uricase with a Trinderlike endpoint (Advia 1650 auto analyzer; Bayer Diagnostics). Insulin concentration was measured with an immunoradiometric assay (Biosource, Nivelle, Belgium) with an intraassay and interassay coefficient of variation of 2.1-4.5% and 4.7-12.2%, respectively. Insulin resistance was estimated using fasting plasma insulin and the homeostasis model assessment of insulin resistance, calculated as insulin × glucose/22.5. Fatty liver was diagnosed by the presence of liver fat identified by liver ultrasound examination. Serum creatinine was measured with the kinetic alkaline picrate (Jaffe) method. The within-batch and total coefficients of variation for creatinine determinations were 1.4-3.9% for the duration of the study. We calculated estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease Study equation.
Statistical analyses
Comparisons of the baseline characteristics of the study population were done with the χ 2 -test, and student t-tests and transformations were conducted for nonparametric variables. The distributions of continuous variables were evaluated. The final number of study participants was categorized into 4 groups according to baseline serum UA level.
Cox proportional hazards models were used to estimate adjusted hazard ratios (aHRs) and 95% confidence intervals (confidence intervals) for incident hypertension, adjusted for pre-specified potential confounders measured at the baseline visit.
Since UA levels are higher in men compared to women, we conducted all analyses separately by sex. For the primary analyses, the study sample was divided in sex-specific quartiles of UA, and we estimated aHRs for incident hypertension comparing the three highest quartiles of UA to the lowest quartile in each sex. As secondary analysis, UA was modeled as a continuous variable in the regression models. The models were first adjusted for age, smoking status, alcohol intake, regular exercise, and educational level (model 1). Model 2 was further adjusted for systolic blood pressure and for BMI. Model 3 was further adjusted for insulin concentration and eGFR. For testing linear risk trends, we used the quartile rank as a continuous variable in the models. We checked the proportional hazards assumption by examining graphs of estimated log (-log) survival, and there was no violation of the proportional hazards assumption.
To test the association between UA concentration change and incident hypertension, the study sample was classified in 4 groups depending on baseline (visit 1) UA concentrations (above vs. below median) and change in UA between visits 1 and 2 (decreased vs. stable or increased concentrations). The 4 groups generated were (i) baseline UA concentration <median and decline in UA concentration (reference group); (ii) baseline UA concentration <median and stable or increased UA concentration; (iii) baseline UA concentration ≥median and decline in UA concentration; and (iv) baseline UA concentration ≥median and stable or increased UA concentration.
Sensitivity and subgroup analyses were undertaken by repeating the analyses after: (i) exclusion of all subjects who were taking antihypertensive medications during follow up, (ii) stratification according to age and drinker.
The statistical analysis was performed using STATA version 11.2 (StataCorp LP, College Station, TX). All reported P values are 2-tailed, and P <0.05 was considered statistically significant.
RESULTS
We followed 96,606 nonhypertensive subjects at baseline for up to 8 years (total median follow-up time 3.3 years; interquartile range, 1.9-5.1 years). The median follow up time from baseline to 1 st visit was 1.88 years, and 3.59 years from 1 st visit to 2 nd visit. At the end of follow-up, 10,405 participants had developed hypertension (incidence rate 30.9 per 1,000 person-years). As expected, participants who developed hypertension were more likely to be male, older, to have a higher baseline BMI, blood pressure, homeostasis model assessment of insulin resistance, and to have a lower eGFR compared to those who did not develop hypertension (Supplementary Table 1 ). Baseline mean (SD) UA concentration was 309.30 (83.27) µmol/l (5.2 (1.4) mg/dl) in individuals without hypertension at follow up, compared with 344.98 (83.27) µmol/l (5.8 (1.4) mg/dl) in those with hypertension at follow up (P < 0.001). In both men and women, UA concentrations were inversely associated with age and eGFR, and positively associated with BMI, blood pressure, and homeostasis model assessment of insulin resistance (Tables 1 and 2 ).
The risk of incident hypertension increased progressively across the quartiles of UA in both men and women (Table 3 ). In the fully adjusted regression model, including adjustments for insulin concentration and eGRF, the HRs (95% confidence interval) for incident hypertension comparing the highest vs. the lowest quartiles of UA were 1.29 (1.19-1.38) in men and 1.24 (1.09-1.42) in women, with statistically significant P value for trend for both gender. When UA was included as a continuous variable in the models, the fully aHRs for incident hypertension associated with a 1 SD increase in UA (1 SD = 82.68 µmol/l (1.39 mg/dl)) were 1.11 (1.08-1.15) and 1.17 (1.08-1.26) for men and women, respectively.
UA concentration increased in 3,266 participants (2,555 men and 711 women) among those who had more than 3 visits and no hypertension at baseline. Among participants with baseline UA concentrations ≥median, the fully aHRs for incident hypertension comparing participants with stable or increased to those with decreased UA concentration were 1.14 (1.03-1.26) and 1.18 (0.98-1.40) in men and women, respectively (Table 4) . Among participants with baseline UA concentration <median, the corresponding HRs were 1.05 (0.94-1.17) and 1.00 (0.82-.22) for men and women, respectively.
Since those with a history of coronary artery disease, cardiovascular disease, cancer, diabetes, and metabolic syndrome at baseline were excluded, the cox proportional methods were repeated after inclusion of these populations to warrant the robustness of the results. Including those subjects did not alter the results with the fully aHR (95% confidence interval) for incident hypertension 1.22 (1.15-1.30) in men and 1.25 (1.10-1.41) in women (Supplementary Table 2 ). Other additional analyses of risk for incident hypertension in individuals not on antihypertensive treatment during follow up, stratified according to age and drinking status, and stratified according to incident diabetes are described, respectively (Supplementary Tables 3-5) . Excluding those who were on antihypertensive medication during follow up did not change the results with aHR (95% confidence interval) 1.26 (1.17-1.36) for men and 1.24 (1.07-1.44) for women. Stratification according to drinking status did not affect the results whereas age and incident diabetes showed significant P value for interaction, 0.015 and 0.017, respectively. We also conducted an additional analyses to seek whether control of gender difference and family history of hypertension would affect the result, respectively, which found to be not (Supplementary Tables 6 and 7) .
DISCUSSION
In this large cohort of apparently healthy men and women, high UA concentrations were associated with an increased risk of incident hypertension, independent of age, smoking status, alcohol intake, exercise, education level, insulin resistance, and renal function. The increase in risk was particularly evident in participants with high initial UA Glucose ≥ 100 mg/dl (%) The association between UA concentrations and incident hypertension has been controversial, partly due to heterogeneity across multiple small studies reported in the literature. A meta-analysis of 18 prospective cohorts that included data from 55,607 people found a 13% increased risk in incident hypertension in subjects with hyperuricemia. 15 Heterogeneity across the studies was considerable (I 2 = 73.4%), and some of these studies adjusted for very few confounders, including one study reporting only unadjusted findings. In this meta-analysis, the association between UA and hypertension was stronger in younger study populations. Our study, with almost double the combined sample size of the studies included in the previous meta-analysis, found a graded association between UA concentrations and incident hypertension across the range of UA levels which persisted after adjusting for multiple risk factors. Moreover, a recent Mendelian randomization study suggested that BMI may confound the association between UA and ischemic heart disease and hypertension. 13 That said, it is plausible that the genetic probe (SLC2A9) used in the Mendelian randomization study was not ideal, since SLC2A9 is involved in renal UA transport and may only affect UA concentration in subjects with renal impairment. 16 There are very limited data in the literature as to whether changes in UA concentrations over time influence the risk of developing hypertension. Our data support the notion that stable or increasing UA concentrations over time in subjects with higher baseline UA concentrations are associated with increased risk of developing incident hypertension and add to the relevance of UA in the development of hypertension.
Several mechanisms may explain a hypertensive effect of UA. Inhibition of uricase in rat models results in a rise in serum UA concentration and in the development of systemic hypertension that is preventable by lowering UA with either xanthine oxidase inhibitors or uricosuric agents. [17] [18] [19] A recent meta-analysis of xanthine oxidase found that, following xanthine oxidase inhibition, brachial artery flowmediated dilatation, and forearm blood flow responses to acetylcholine infusion increased compared with changes in the noninfused control arm. 20 Reduction of UA concentration lowers blood pressure, suggesting a direct pathophysiological role of UA in the development of hypertension, and consequently there has been renewed interest in whether allopurinol treatment lowers blood pressure. The change in blood pressure after allopurinol initiation has been studied, 21 and allopurinol usage was independently associated with a fall in both systolic and diastolic blood pressure.
UA has both pro-oxidant and antioxidant capabilities, and it has been suggested that there may be a molecular switch to regulate the role of UA as antioxidant or pro-oxidant in different tissues. 14 This may contribute to the difficulty in establishing a relationship between serum UA and chronic diseases. UA upregulates renin-angiotensin system and angiotensin II and causes an increase in reactive oxygen species production in human endothelial cells 22 and in adipose tissue. 23 This mechanism may thus provide a direct pathway by which UA may affect blood pressure.
There are some limitations to our study that need to be considered. First of all, the diagnoses of hypertension at each screening visit were based on measurement taken at a single visit, which may induce unreliable result and lead to misclassification of blood pressure status. Furthermore, random measurement error may also affect UA and other confounders, after the effect of random measurement error is likely to attenuate the observed associations. As with other observational studies, we cannot exclude the possibility of residual confoundings, although we adjusted for BMI, eGFR, insulin concentration, and several other risk factors. Finally, our study comprised of apparently healthy young and middleaged Korean men and women. Approximately 80% of the participants were employees of various companies and therefore these individuals are not entirely representative of the whole population of Korea. Thus, our findings may not apply to other age groups or to other race/ethnicities.
Several advantages of this cohort, however, add to the strength of the findings. In addition to the large sample size, the data was collected under standardized conditions and followed uniform procedures by trained staffs. Laboratory methods also were carefully standardized with rigorous internal and external quality controls. Finally a major advantage of our study is that our sample was comprised of young and middle-aged apparently healthy men and women, while participants in many other cohorts tended to be older. Our findings are thus less likely to be affected by selection bias and other biases due to disease development, presence of comorbidities, and use of multiple medications that affect older cohorts.
In conclusion, high initial UA concentration and increases in UA concentration over time increase the risk for incident hypertension therefore UA concentration should be considered as independent risk factors for hypertension.
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